Bioprotesi aortiche degenerate: il parametro del "profilo di rischio"
ESC 2019 - PARIS
Linee guida ESC sull'ipertensione un anno dopo: quali novità
it
Prof. Giuseppe Mancia
More women in future studies to investigate gender differences
en
Prof. Franz Weidinger
Women's involvement in decision-making improves outcomes
en
Prof. Cecilia Linde
The role of SGLT2i in cardiovascular risk, kidney disease and HF
en
Prof. Christoph Wanner
Do women experience heart failure in a different way?
en
Prof. Ileana L. Piña
Rivascolarizzazione "culprit" o completa nella SCA-STEMI?
it
Prof. Francesco Romeo
Male and female physicians: differences in treating patients
en
Prof. Eva Swahn
Wearables, implantables, AI in the future of AF detection
en
Prof. Thorsten Lewalter
Gender differences in the diagnosis and treatment of Isch. H.D.
en
Prof. Raffaele Bugiardini
Managing mitral regurgitation in heart failure
en
Prof. Frank Ruschitzka
EXPAND Study: next generation MitraClip, performance and safety
en
Prof. R. Von Bardeleben
Women and men: different outcomes from similar treatments
en
Prof. Donna Fitzsimons
Bioprotesi aortiche degenerate: il parametro del "profilo di rischio"
it
Prof. Gino Gerosa
Women's peculiarities may lead to worse outcomes in PCI
en
Dr. Patrizia Presbitero
Controversies in the treatment of aortic valve disease
en
Prof. Ottavio Alfieri